» Articles » PMID: 19953330

Is Total Mesorectal Excision Always Necessary for T1-T2 Lower Rectal Cancer?

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2009 Dec 3
PMID 19953330
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The goal of this multicenter study was to clarify the determinants of local excision for patients with T1-T2 lower rectal cancer.

Methods: Data from 567 consecutive patients who underwent radical resection for T1-T2 lower rectal cancer at 12 institutions between 1991 and 1998 were reviewed. Rates of lymph node metastasis were investigated using a tree analysis, which was hierarchized using independent risk factors for nodal involvement.

Results: The independent risk factors for lymph node metastasis were female gender, depth of tumor invasion, histology other than well-differentiated adenocarcinoma, and lymphatic invasion. According to the first three parameters that can be obtained preoperatively, only 0.99% of the patients without risk factors had lymph node metastasis. On the other hand, even if the lower rectal cancer was at stage T1, women with histological types other than well-differentiated adenocarcinoma had an approximately 30% probability of having lymph node metastasis. Lymphatic invasion was most useful to predict nodal involvement among patients with T2 lower rectal cancer. The rates of lymph node metastasis in T2 patients with and without lymphatic invasion were 32.9% and 9.1%, respectively.

Conclusions: Gender is one of the most important predictors for lymph node metastasis in patients with early distal rectal cancer. Three parameters, including depth of tumor invasion, histology, and gender, are useful determinants for local excision. Additional studies are required to establish the minimum optimal treatment for T2 lower rectal cancer.

Citing Articles

Lymph node metastasis following chemoradiotherapy in advanced rectal cancer: ypT2-focused analyses of total mesorectal excision specimens.

Singhi A, Lee T, Ahn H, Shin H, Choi M, Jo M Tech Coloproctol. 2024; 29(1):15.

PMID: 39661208 DOI: 10.1007/s10151-024-03046-7.


Lymphovascular invasion is a dominant risk factor for lymph node metastasis in T2 rectal cancer.

Medic S, Nilsson E, Ronnow C, Thorlacius H Endosc Int Open. 2024; 12(9):E1056-E1062.

PMID: 39268155 PMC: 11392589. DOI: 10.1055/a-2405-1117.


Risk factors for lymph node metastasis in T2 colorectal cancer: a systematic review and meta-analysis.

Watanabe J, Ichimasa K, Kudo S, Mochizuki K, Tan K, Kataoka Y Int J Clin Oncol. 2024; 29(7):921-931.

PMID: 38709424 DOI: 10.1007/s10147-024-02547-7.


Nonsurgical Management Following Local Resection for Early Rectal Cancer in Patients with High-risk Factors: A Single-institute Experience.

Nishizaki D, Hoshino N, Hida K, Nishikawa Y, Horimatsu T, Minamiguchi S J Anus Rectum Colon. 2020; 4(4):174-180.

PMID: 33134598 PMC: 7595679. DOI: 10.23922/jarc.2020-019.


Evaluation of risk factors for lymph node metastasis in T2 lower rectal cancer to perform chemoradiotherapy after local resection.

Ushigome H, Ohue M, Kitamura M, Nakatsuka S, Haraguchi N, Nishimura J Mol Clin Oncol. 2020; 12(4):390-394.

PMID: 32190324 PMC: 7057958. DOI: 10.3892/mco.2020.1993.